4//SEC Filing
GENESIS BIOVENTURES INC 4
Accession 0001181431-07-070568
CIK 0001084966operating
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:43 PM ET
Size
10.5 KB
Accession
0001181431-07-070568
Insider Transaction Report
Form 4
GENESIS BIOVENTURES INCGBIW.OB
FG2 Advisors, LLC
10% Owner
Transactions
- Purchase
Common Stock (par value $0.0001)
2007-09-21$0.05/sh+50,000$2,500→ 22,907,937 total(indirect: See footnotes)
Passin James
10% Owner
Transactions
- Purchase
Common Stock (par value $0.0001)
2007-09-21$0.05/sh+50,000$2,500→ 22,907,937 total(indirect: See footnotes)
Sawikin Harvey
10% Owner
Transactions
- Purchase
Common Stock (par value $0.0001)
2007-09-21$0.05/sh+50,000$2,500→ 22,907,937 total(indirect: See footnotes)
Firebird Global Master Fund II, Ltd.
10% Owner
Transactions
- Purchase
Common Stock (par value $0.0001)
2007-09-21$0.05/sh+50,000$2,500→ 22,907,937 total(indirect: See footnotes)
Footnotes (2)
- [F1]These securities are held directly by Firebird Global Master Fund II, Ltd. ("Global Fund II"). FG2 Advisors, LLC ("FG2") acts as investment advisor to Global Fund II, and shares voting and investment control with respect to these securities with Global Fund II. James Passin is the control person of FG2, and controls the voting and investment decisions of FG2. Mr. Sawikin may be deemed to control FG2, and to share voting and investment control with respect to these securities. FG2, Mr. Passin and Mr. Sawikin each disclaim beneficial ownership of all shares except to the extent of any pecuniary interest therein and this filing should not be deemed an admission of beneficial ownership for Section 16 purposes or any other purpose.
- [F2]James Passin and Harvey Sawikin may each be deemed to have an indirect interest in certain of the securities owned by Global Fund II through each of their indirect holdings therein. Each of Mr. Passin and Mr. Sawikin disclaims beneficial ownership of all securities except to the extent of any pecuniary interest therein and this filing should not be deemed an admission of beneficial ownership for Section 16 purposes or any other purpose.
Documents
Issuer
GENESIS BIOVENTURES INC
CIK 0001084966
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001084966
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:43 PM ET
- Size
- 10.5 KB